Susan L. Kelley - 31 May 2024 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Director
Signature
/s/ Jason Throne, as Attorney-in-Fact for Susan L. Kelley
Issuer symbol
IDYA
Transactions as of
31 May 2024
Net transactions value
$0
Form type
4
Filing time
31 May 2024, 16:38:32 UTC
Previous filing
21 Jun 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Award $0 +16,200 $0.000000 16,200 31 May 2024 Common Stock 16,200 $36.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney